ModifiedColorado Rocky Mountain Health PlansPolicy 2026T0621N

Sacroiliac Joint Interventions (Injections and Fusion) — Coverage Criteria

Clinical coverage guidance for intra-articular sacroiliac (SI) joint injections and SI joint fusion procedures for UnitedHealthcare Commercial and Individual Exchange plans; includes diagnostic blocks, minimally invasive and open fusion, and references to related policies and InterQual criteria.

Policy Summary

PayerColorado Rocky Mountain Health Plans

PolicySacroiliac Joint Interventions (Injections and Fusion) — Coverage Criteria

Policy CodePolicy 2026T0621N

Change TypeCPT code updatesshared policy version added

Effective DateJan 1, 2026

Next Review DateN/A

Key ActionObtain prior authorization per member plan and document ≥6 months of failed conservative treatment plus diagnostic image-guided SIJ blocks showing ≥75% pain relief on two occasions.

SourceLink

POLICY UPDATE CHANGES

Updated list of applicable CPT codes to reflect annual edits and revised descriptions for 27278 and 27279.

Created shared policy version to support application to Oxford plan membership.

Archived previous policy versions 2025T0621M and PAIN 027.9.

CPT 27278-27280, 64451Procedure codes listed

iFuse (TTI)Strongest evidence device

≥75%Diagnostic block threshold

≥6 months

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Minimum nonoperative duration

OxfordShared version applied

Coverage Criteria for SI Joint Injections and Fusion

InterQual-referenced medical necessity for SI injections and fusion

Covered when ALL of the following are met per referenced InterQual criteria

InterQual-based coverage: Intra-articular SI joint injections and minimally invasive or open SI joint fusion are considered proven and medically necessary in certain circumstances when the specific clinical criteria in the referenced InterQual CPs are met.Refer to InterQual CP: Procedures, Sacroiliac (SI) Joint Injection and InterQual Client Defined CP: Procedures, Sacroiliac (SI) Joint Fusion (Custom) UHG

Providers must follow InterQual criteria and site-of-service review; see policy text for links to InterQual.

Unproven / Not Medically Necessary

Not covered when:

Unproven indications: Sacral lateral branch nerve blocks used as a diagnostic tool prior to radiofrequency ablation are unproven and not medically necessary due to insufficient evidence of efficacy and anatomic/physiologic limitations.

Policy explicitly identifies these blocks as unproven and NMN.

Other unproven uses: Fusion of the SI joint for back pain with devices or for indications not specified as proven (i.e., other than minimally invasive TTI systems or open fusion when InterQual criteria met) is considered unproven and not medically necessary due to insufficient evidence of efficacy.

Coverage limited to devices/indications supported by referenced criteria; other uses are NMN.

Evidence-based distinctions by device/technique

Device- and technique-specific evidence considerations

iFuse (Titanium Triangular Implant): Minimally invasive SIJ fusion using a triangular titanium implant system (iFuse/TTI) is supported by randomized trials and systematic reviews demonstrating improvements in pain, disability, and QOL versus nonoperative management and is identified as having the most robust evidence (Level 1 evidence).

Multiple RCTs and meta-analyses cited; NICE recommends iFuse.

Other implant systems (CTIs, bone allografts, LinQ, SI-LOK, Rialto): Evidence for other minimally invasive implant systems (e.g., cylindrical threaded implants, engineered bone allografts, LinQ, SI-LOK, Rialto) is limited, often nonrandomized or single-arm, and comparative effectiveness versus TTI/iFuse is unclear; available studies have methodological limitations and small samples.

ECRI and Hayes reviews and systematic reviews note low or very-low quality evidence and need for comparative randomized trials.

Indications for minimally invasive SIJ fusion (per cited specialty societies)

Covered when ALL of the following are met

Society-based indication bundle: 1) Chronic SIJ pain consistent with history and examination (nonradicular pain, typically unilateral, maximal below L5, localized tenderness/Fortin's point); 2) Positive physical examination with a cluster of provocative maneuvers (minimum three tests per society guidance); 3) Diagnostic imaging that excludes other causes and demonstrates SIJ injury/degeneration (plain radiographs plus CT or MRI of the SIJ; AP pelvis to exclude hip pathology; lumbar spine CT or MRI); 4) Confirmation of the SIJ as the pain generator with ≥75% acute reduction in pain following image-guided, contrast-enhanced intra-articular SIJ block on two separate occasions; 5) Failure of at least six months of intensive nonoperative treatment including medication optimization, activity modification, and active therapeutic exercise and at least one therapeutic intra-articular SIJ steroid injection; and 6) Absence of generalized pain disorders or other diagnoses that better explain the patient's pain.n/a

Criteria synthesized from NASS, ISASS, and other society recommendations cited in policy.

Fusion of the sacroiliac (SI) joint for treatment of back pain presumed to originate from the SI joint is considered unproven and not medically necessary when performed for indications other than those specifically identified as proven in this policy. The policy states that minimally invasive SIJF using a Titanium Triangular Implant system and open SIJ fusion may be considered proven and medically necessary in certain circumstances when InterQual criteria are met; all other fusion indications and devices not listed are regarded as unsupported by sufficient evidence and therefore not medically necessary.

Patients with less than six months of back pain, those who have failed to pursue or complete conservative treatment (unless contraindicated), patients whose pain is not confirmed by diagnostic SIJ block, or those with other pathology that better explains the pain are excluded from consideration for minimally invasive SIJ fusion. These limitations mirror society guidance requiring a minimum of six months of intensive nonoperative care and confirmation of SIJ as the pain generator prior to fusion.

FDA information is provided for reference only: FDA approval alone is not a basis for coverage. The SIJ injection procedure itself is not regulated by the FDA, although any devices, drugs, biologics, or tests used as part of the procedure may be subject to FDA regulation. Providers may consult the FDA PMN database for product-specific regulatory information.

Use of sacral lateral branch nerve blocks as a diagnostic test is considered unproven and not medically necessary. The policy notes anatomic and physiologic limitations, sparse published data, and insufficient evidence quality to support their effectiveness for diagnostic use prior to procedures such as radiofrequency ablation.

Evidence for alternative implant systems such as cylindrical threaded implants (CTIs) and several other minimally invasive device designs is limited and of very low quality; current literature does not provide sufficient comparative-effectiveness data to conclude these devices are effective and safe. Reviews (e.g., Hayes, ECRI) and individual studies report uncertainty about long-term benefit and higher risk of bias for CTIs, indicating the evidence is insufficient to support coverage as proven.

Applicable Procedure and CPT Codes

Applicable procedure CPT codesCPT

27278	Arthrodesis, sacroiliac joint, percutaneous or minimally invasive, with image guidance... placement of intra-articular device(s), without cortical piercing.
27279	Arthrodesis, sacroiliac joint, percutaneous or minimally invasive, with image guidance... placement of transarticular device(s) and/or intra-articular device(s) piercing the lateral or medial cortices of the ilium and the lateral cortex of the sacrum.
27280	Arthrodesis, sacroiliac joint, open, includes obtaining bone graft, including instrumentation, when performed.
64451	Injection(s), anesthetic agent(s) and/or steroid; nerves innervating the sacroiliac joint, with image guidance (i.e., fluoroscopy or computed tomography).

Applicable CPT Codes (updated)CPT

27278	revision noted — description revised in applicable codes update
27279	revision noted — description revised in applicable codes update

inv-12: Diagnostic SIJ block pain reduction threshold (>= 75% on two occasions)

Diagnostic pain reduction threshold≥ 75% reduction of pain for the expected duration of the anesthetic after an image-guided, contrast-enhanced intra-articular SIJ injection, documented on two separate occasions

Documentation methodPain reduction should be documented (e.g., pain diary) for the expected duration of the anesthetic used

PurposeUsed to confirm the sacroiliac joint as the pain generator prior to consideration of minimally invasive SIJ fusion

inv-13: Pain severity threshold (ISASS) — numeric rating >=5

Numeric pain severity thresholdPain rating at least 5 on the 0–10 numeric rating scale (0 = no pain, 10 = worst imaginable)

Provider Actions, Authorization and Documentation

Prior Authorization

Prior Authorization Required

Prior authorization is required for sacroiliac (SI) joint injections and SI joint fusion procedures. Prior authorization decisions are based on InterQual clinical criteria and site-of-service review where applicable. Requests should be submitted before the procedure when possible to avoid claim denials or delays.

Submit prior authorization per payer guidelines and include all required documentation (see items below).
Site-of-service review may be required for SI joint injections — refer to the payer's outpatient surgical procedures/site-of-service policy.

Note

Confirm Prior Authorization per Member Plan

Confirm whether prior authorization is required for the requested service under the member's specific plan and benefits. Benefit coverage is determined by the member specific benefit plan document and applicable laws; the plan document governs in case of conflict.

Verify benefit coverage and any prior authorization requirements through the payer’s provider portal or by contacting provider services.

Nonoperative Management Requirements Prior to Fusion

Conservative management should have been attempted or considered prior to fusion (refer to InterQual)

Conservative (nonoperative) management should have been attempted or considered prior to fusion per referenced trials and guidelines (refer to InterQual for explicit criteria).

Conservative care prerequisite: Nonoperative management should be attempted or considered prior to surgical fusion; randomized trials and systematic reviews use conservative care as the comparator for MIS SIJ fusion.Refer to InterQual for explicit regimen details

Evidence base for fusion compares devices to optimized nonoperative care; documentation of prior conservative care is required for prior authorization.

Documented failure of conservative management (>= 6 months)

Documented failure of conservative management (minimum duration requirement)

Duration and components: At least 6 months of intensive nonoperative treatment that includes medication optimization, activity modification, and active therapeutic exercise targeted to the lumbar spine/pelvis/SIJ/hip, and at least one therapeutic intra-articular SIJ steroid injection, with continued pain that interferes with activities of daily living or results in functional disability.

Procedure Frequency, Image Guidance and Procedural Notes

inv-37: Image guidance required for injections (CPT 64451) and fusion (CPT 27278-27279)

Image guidance required for SIJ injections (CPT 64451)Injections require image guidance such as fluoroscopy or CT per CPT description and policy statements

Image guidance required for minimally invasive SIJ fusion (CPT 27278–27279)Minimally invasive sacroiliac joint arthrodesis CPT codes specify performance with image guidance

Accepted modalitiesFluoroscopy or computed tomography (CT) are specified as examples of acceptable image guidance

inv-38: Image-guided, contrast-enhanced intra-articular SIJ injection — diagnostic block on two occasions

Diagnostic injection protocolImage-guided, contrast-enhanced intra-articular SIJ injection used to confirm SIJ as pain generator

Repetition requirement

Imaging and Preoperative Workup

Billing Rule

Use fluoroscopy or CT for procedure guidance

Fluoroscopy or CT image guidance is required for SI joint injections and for minimally invasive SI fusion procedures per the CPT descriptions and policy statements; ensure imaging guidance is documented in the record.

Documentation Required

Obtain specified preoperative imaging

Preoperative workup for SIJ fusion should include plain radiographs and CT or MRI of the SI joint, an AP pelvis radiograph to rule out hip pathology, and lumbar spine imaging (CT or MRI) to exclude neural compression or other degenerative conditions.

Note

Background and Definitions

Sacroiliac joint fusion (SIJF) is a surgical procedure performed to stabilize the sacrum and ilium for conditions such as trauma, infection, neoplasm, or spinal instability and to treat chronic SIJ dysfunction when conservative measures fail. Minimally invasive SIJF places implants across the SI joint (for example, Titanium Triangular Implants such as the iFuse system) using small lateral or posterior approaches with image guidance; randomized trials and systematic reviews support benefit for the iFuse device in appropriately selected patients.

inv-27: Provocative Tests definitions (thigh thrust, Gaenslen's, Patrick/Fabere etc.)

Thigh thrust testApplying downward pressure along the femur while supine; reproduction of pain at the ilium or SI joint suggests SIJ dysfunction

Gaenslen's testPerformed supine by flexing one hip and extending the other toward the opposite hip to stress both SI joints; reproduction of typical pain is positive

Patrick/Faber testFlexion, abduction, external rotation, and extension of the affected leg with slow lowering; reproduction of buttock/SIJ pain indicates a positive test

Services Not Covered

Not covered: sacral lateral branch nerve blocks when used as a diagnostic tool prior to radiofrequency ablation, because evidence is insufficient and anatomic limitations reduce diagnostic reliability. Minimally invasive SIJ fusion is not covered when patient selection does not meet required prerequisites (for example, lack of documented ≥6 months of intensive nonoperative care or absence of diagnostic confirmation of the SIJ as the pain generator). Additionally, use of certain alternative devices (such as cylindrical threaded implants) is excluded from being considered proven due to limited, very-low-quality evidence; coverage is limited to devices and indications supported by higher-quality evidence and InterQual criteria.

Policy Summary

PayerColorado Rocky Mountain Health Plans

PolicySacroiliac Joint Interventions (Injections and Fusion) — Coverage Criteria

Policy CodePolicy 2026T0621N

Change TypeCPT code updatesshared policy version added

Effective DateJan 1, 2026

Next Review DateN/A

Key ActionObtain prior authorization per member plan and document ≥6 months of failed conservative treatment plus diagnostic image-guided SIJ blocks showing ≥75% pain relief on two occasions.

SourceLink

On This Page

Threshold cited by ISASS as part of indications for minimally invasive SIJ fusion

Relation to functionMay be associated with significant limitations in activities of daily living per ISASS guidance

If the member’s plan is Medicare Advantage, confirm whether different coverage rules or MAO-specific determinations apply.

Documentation Required

Key Documented Prerequisites

Key clinical prerequisites must be clearly documented in the medical record to support medical necessity for minimally invasive or open SI joint fusion.

Documentation of at least 6 months of intensive nonoperative treatment addressing medication optimization, activity modification, and active therapeutic exercise targeted at the lumbar spine, pelvis, SIJ and hip.
At least 75% pain reduction documented on two separate image‑guided, contrast‑enhanced intra‑articular SIJ injections for the expected duration of the anesthetic, or ≥75% acute decrease in pain on a diagnostic fluoroscopically guided intra‑articular SIJ block (per ISASS/NASS criteria).
Failure to respond to at least one therapeutic intra‑articular SIJ steroid injection (therapeutic trial).
Clinical history of nonradicular, typically unilateral pain localized over the posterior SIJ and physical exam consistent with SIJ pain (positive cluster of provocative tests).
Imaging studies (plain radiographs and CT or MRI of SIJ; AP pelvis radiograph; lumbar spine CT or MRI) to exclude other causes and demonstrate SIJ injury/degeneration.
Absence of generalized pain disorders (e.g., fibromyalgia) or other diagnoses that better explain symptoms.

Prior Authorization

Member Benefit Verification Required

Verify member benefits and eligibility prior to authorization and procedure scheduling. Medical record documentation may be requested to assess whether clinical criteria are met and does not guarantee coverage.

Check member eligibility and benefits for coverage, prior authorization, and any plan-specific limitations or exclusions.
Be prepared to submit medical records (history, exam findings, imaging, pain diaries showing percent reduction after diagnostic injections, and conservative care documentation) upon request.

Documentation Required

Device/Drug Documentation and Plan Reference

Document details of any devices, implants, drugs, or biologics used for SI joint procedures. Reference applicable FDA information and the payer's device/drug policies when submitting authorization requests.

Include device/implant model, manufacturer, and FDA clearance/approval status in the request when applicable.
For minimally invasive SIJ fusion, specify the implant system (e.g., Titanium Triangular Implant system) if used and include supporting clinical rationale and relevant InterQual criteria.
If medications (e.g., corticosteroids, local anesthetic) are used for injections, document the drug, dose, route, and rationale. Note that SIJ injection procedures themselves are not subject to FDA device regulation, but devices and drugs used may be.

Documentation Required

Clinical Diagnostic and Conservative Management Context

Clinical diagnostic and conservative management context must be included to demonstrate that nonoperative care was attempted and that diagnostic procedures support the SIJ as the pain generator.

Describe prior conservative therapies (physical therapy, medication optimization including NSAIDs or opioids if appropriate, activity modification, home exercise program) and duration (minimum 6 months per NASS/ISASS when applicable).
Provide results of provocative physical exam maneuvers and documentation of how many tests reproduced typical pain (cluster of tests).
Include pain diary or documentation showing percent pain relief following diagnostic/contrast-enhanced intra‑articular SIJ injections.
Explain why conservative measures were insufficient and how the proposed procedure is expected to improve function and reduce pain.

Documentation Required

Conservative Therapy Prerequisite

A trial of conservative therapy is required prior to consideration of SI joint fusion except when contraindicated. Conservative management must be appropriately documented.

Minimum six months of nonoperative treatment that includes medication optimization, activity modification, and active therapeutic exercise targeted at the lumbar spine, pelvis, SIJ and hip.
Documentation of adherence to and response (or lack of response) to conservative measures is required for authorization review.

Step Therapy

Step Therapy — Member‑Specific Rules

Step therapy or member‑specific prior attempt rules may apply depending on the member's benefit plan. Confirm whether step therapy requirements exist and document prior treatments tried and failed.

If the plan requires specific step therapy (e.g., trial of injections before fusion), document dates, therapies, and outcomes.
If step therapy rules are applicable, authorization may be denied without evidence of the required prior steps.

Consistent with NASS and ISASS recommendations and required for prior authorization/documentation.

Additional conservative-treatment related nodes (placeholder)

Additional conservative-treatment related nodes (operational details to document prior to authorization)

Documentation elements: Documented history of failed nonoperative management for at least six months; detailed physical exam with positive provocative maneuvers (minimum three tests); imaging (plain radiographs and CT or MRI of the SIJ, AP pelvis, and lumbar imaging) to exclude other causes; results of image-guided, contrast-enhanced intra-articular SIJ block showing required percent pain reduction on two occasions; and record of at least one therapeutic intra-articular SIJ steroid injection.See diagnostic block threshold: >=75% pain reduction on two occasions

Medical records may be requested to verify these elements for prior authorization and claim review.

Exclusions related to conservative care: Patients with less than six months of symptoms, failure to pursue or complete conservative treatment (unless contraindicated), pain not confirmed by diagnostic SIJ block, or other pathology sufficiently explaining the pain do not meet criteria for fusion coverage.

ISASS lists these as contraindications/limits to coverage.

Diagnostic intra-articular SIJ block must be performed on two separate occasions demonstrating the required pain relief

DocumentationPain reduction should be documented for the expected duration of the anesthetic (e.g., pain diary) and correlated with clinical findings

inv-39: minimally invasive sacroiliac joint fusion frequency/notes

Prerequisite timing and therapiesMinimally invasive SIJ fusion requires failure of ≥6 months of intensive nonoperative treatment (medication optimization, activity modification, active therapeutic exercise) and at least one therapeutic SIJ injection prior to fusion consideration

Indication bundleCoverage based on society recommendations requires: localized SIJ pain, positive provocative maneuvers, imaging excluding other causes, diagnostic block confirmation, and failed conservative care

ExclusionsNot indicated for patients with <6 months of symptoms, pain not confirmed with diagnostic SIJ block, failure to pursue conservative care, or other pathology better explaining pain

Imaging cited in literature but no explicit intervals

Clinical references and trials cited in the policy typically include imaging for diagnosis and device placement, but the policy does not specify explicit imaging intervals or frequency; follow cited society guidance and procedural coding requirements.

inv-28: Minimally invasive SIJF definition

DefinitionPercutaneous procedure placing implants (e.g., Titanium Triangular Implants such as iFuse) across the SI joint via small lateral or posterior incisions using image guidance to stabilize and fuse the joint

Approach and instrumentationSmall lateral/transiliac or posterior approaches with percutaneous implant placement under image guidance

Evidence contextMinimally invasive techniques (notably triangular titanium implants) have randomized trials and systematic reviews supporting improvements in pain and function versus nonoperative management

inv-29: Sacroiliac Joint Fusion (Arthrodesis) definition

DefinitionSurgical joining (arthrodesis) of the sacrum and ilium to stabilize the sacroiliac joint and reduce low back or buttock pain; may be performed via minimally invasive or open techniques

Open technique descriptionOpen SIJ fusion involves a larger incision, separation of muscles/tissues, cartilage removal, and placement of bone graft with instrumentation

GoalIntended to stabilize the joint and alleviate or reduce low back pain related to SIJ dysfunction

inv-30: Triangular titanium implants (TTI) / iFuse implant system definition and evidence note

Device descriptionTriangular titanium implants (e.g., iFuse Implant System) are triangular dowel-shaped titanium implants placed transiliac to stabilize the SI joint

Evidence summaryMultiple randomized trials, systematic reviews, and long-term studies report pain, disability, and quality-of-life improvements with iFuse compared with nonoperative management; NICE recommends iFuse as an option

Regulatory status noteSeveral triangular titanium implant systems have received FDA marketing clearance; device-specific data and long-term outcomes are available in cited literature

inv-31: Cylindrical threaded implants (CTI) / Rialto, SI-LOK definition and evidence limitations

Device descriptionCylindrical threaded implants (CTIs) are screw-type implants (e.g., Rialto, SI-LOK) used for SIJ fusion

Evidence limitationsAvailable evidence for CTIs is limited and of very low quality, with few comparative studies and uncertainty about long-term efficacy and safety

Comparative concernsSome studies suggest higher revision and complication rates with CTI systems compared with triangular titanium implants; further randomized comparative data are needed

inv-32: Minimally invasive sacroiliac joint fusion overview

OverviewMinimally invasive SIJ fusion comprises percutaneous lateral/transiliac or posterior approaches using implants (triangular titanium implants, cylindrical threaded implants, or bone allografts) placed under image guidance to stabilize and promote fusion

Typical goals and outcomesAimed at reducing pain and improving function and quality of life in patients with chronic SIJ pain unresponsive to conservative care; evidence strongest for triangular titanium implants

Evidence and limitationsSystematic reviews and RCTs support benefit for certain devices (iFuse), while evidence for many alternative devices is limited by small sample sizes and nonrandomized designs

inv-33: SIJ injection definition

DefinitionInjection of corticosteroids and/or local anesthetics into the sacroiliac joint as a diagnostic or therapeutic procedure; the injection itself is not FDA-regulated though devices/drugs used may be

Diagnostic roleIntra-articular SIJ injections (contrast-enhanced, image-guided) are used diagnostically to confirm the SIJ as the pain generator when they produce the required pain relief

CodingCPT 64451 describes injections to nerves innervating the sacroiliac joint with image guidance (fluoroscopy or CT)